UBS Group’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $719K | Sell |
|
|||||
|
2024
Q4 | $638K | Buy |
|
|||||
|
2024
Q3 | $53.6K | Sell |
|
|||||
|
2024
Q2 | $118K | Sell |
|
|||||
|
2024
Q1 | $563K | Buy |
|
|||||
|
2023
Q4 | $187K | Sell |
|
|||||
|
2023
Q3 | $17.4M | Buy |
|
|||||
|
2023
Q2 | $118K | Sell |
|
|||||
|
2023
Q1 | $288K | Buy |
|
|||||
|
2022
Q4 | $48.3K | Buy |
|
|||||
|
2022
Q3 | $19K | Sell |
|
|||||
|
2022
Q2 | $35K | Buy |
|
|||||
|
2022
Q1 | $48K | Sell |
|
|||||
|
2021
Q4 | $57K | Buy |
|
|||||
|
2021
Q3 | $77K | Buy |
|
|||||
|
2021
Q2 | $109K | Sell |
|
|||||
|
2021
Q1 | $685K | Buy |
|
|||||
|
2020
Q4 | $655K | Buy |
|
|||||
|
2020
Q3 | $321K | Buy |
|
|||||
|
2020
Q2 | $61K | Sell |
|
|||||
|
2020
Q1 | $77K | Sell |
|
|||||
|
2019
Q4 | $551K | Sell |
|
|||||
|
2019
Q3 | $558K | Buy |
|
|||||
|
2019
Q2 | $417K | Sell |
|
|||||
|
2019
Q1 | $661K | Buy |
|
|||||
|
2018
Q4 | $164K | Sell |
|
|||||
|
2018
Q3 | $283K | Sell |
|
|||||
|
2018
Q2 | $427K | Sell |
|
|||||
|
2018
Q1 | $474K | Buy |
|
|||||
|
2017
Q4 | $274K | Sell |
|
|||||
|
2017
Q3 | $534K | Sell |
|
|||||
|
2017
Q2 | $2.92M | Buy |
|
|||||
|
2017
Q1 | $2.05M | Sell |
|
|||||
|
2016
Q4 | $2.69M | Buy |
|
|||||
|
2016
Q3 | $207K | Sell |
|
|||||
|
2016
Q2 | $161K | Buy |
|
|||||
|
2016
Q1 | $102K | Sell |
|
|||||
|
2015
Q4 | $2.11M | Buy |
|
|||||
|
2015
Q3 | $73K | Buy |
|
|||||
|
2015
Q2 | $66K | Buy |
|
|||||
|
2015
Q1 | $49K | Sell |
|
|||||
|
2014
Q4 | $71K | Buy |
|